Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel inhibitor of sphingolipid synthesis opens a new approach for anti-HCV drug design

Oct. 28, 2005

AT-1001 completes phase I study, receives fast track designation

Oct. 28, 2005

Enrollment completed in phase IIb HCV study of Albuferon plus ribavirin

Oct. 28, 2005

Novel treatment options for hepatic disorders described in recent patent literature

Oct. 26, 2005

Schering AG plans additional phase III Crohn's disease trial for sargramostim

Oct. 24, 2005

Polypill therapy may result promising for NAFLD

Oct. 21, 2005

Novel treatment options for hepatitis C imparted in recent literature

Oct. 20, 2005

Havrix approved for children aged 12 months and older

Oct. 20, 2005

DDP-225 begins phase II trial for diarrhea-predominant IBS

Oct. 20, 2005

Altana patents claim gastric acid antisecretory agents

Oct. 19, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...